Yatsen Holding Limited

NYSE:YSG Stock Report

Market Cap: US$395.0m

Yatsen Holding Valuation

Is YSG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of YSG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
US$100.79
Fair Value
95.7% undervalued intrinsic discount
3
Number of Analysts

Below Fair Value: YSG ($4.38) is trading below our estimate of fair value ($100.79)

Significantly Below Fair Value: YSG is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for YSG?

Key metric: As YSG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for YSG. This is calculated by dividing YSG's market cap by their current revenue.
What is YSG's PS Ratio?
PS Ratio0.9x
SalesCN¥3.39b
Market CapCN¥2.86b

Price to Sales Ratio vs Peers

How does YSG's PS Ratio compare to its peers?

The above table shows the PS ratio for YSG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.9x
UPXI Upexi
20.5xn/aUS$428.5m
NUS Nu Skin Enterprises
0.2xn/aUS$284.1m
USNA USANA Health Sciences
0.6x8.4%US$528.5m
OLPX Olaplex Holdings
2.2x1.7%US$885.5m
YSG Yatsen Holding
0.9x8.0%US$395.0m

Price-To-Sales vs Peers: YSG is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (5.9x).

Price to Sales Ratio vs Industry

How does YSG's PS Ratio compare vs other companies in the US Personal Products Industry?

27 CompaniesPrice / SalesEstimated GrowthMarket Cap
EPC Edgewell Personal Care
0.6x2.3%US$1.30b
HLF Herbalife
0.1x3.4%US$691.54m
NUS Nu Skin Enterprises
0.2xn/aUS$284.10m
NATR Nature's Sunshine Products
0.6x1.7%US$243.15m
YSG 0.9xIndustry Avg. 1.2xNo. of Companies27PS02.44.87.29.612+
27 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: YSG is good value based on its Price-To-Sales Ratio (0.9x) compared to the US Personal Products industry average (1.3x).

Price to Sales Ratio vs Fair Ratio

What is YSG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

YSG PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ratio1.2x

Price-To-Sales vs Fair Ratio: YSG is good value based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (1.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst YSG forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$4.38
US$4.63
+5.6%
32.8%US$6.76US$3.40n/a3
May ’26US$4.15
US$4.66
+12.2%
32.6%US$6.80US$3.44n/a3
Apr ’26US$4.71
US$4.66
-1.1%
32.6%US$6.80US$3.44n/a3
Mar ’26US$3.81
US$4.09
+7.3%
19.1%US$5.18US$3.40n/a3
Feb ’26US$3.17
US$4.09
+29.0%
19.1%US$5.18US$3.40n/a3
Jan ’26US$3.98
US$4.07
+2.2%
20.0%US$5.20US$3.31n/a3
Dec ’25US$5.02
US$4.09
-18.4%
20.2%US$5.24US$3.33n/a3
Nov ’25US$3.89
US$3.99
+2.5%
14.6%US$4.78US$3.40n/a3
Oct ’25US$3.46
US$3.99
+15.2%
14.6%US$4.78US$3.40n/a3
Sep ’25US$3.19
US$4.12
+29.3%
10.8%US$4.75US$3.76n/a3
Aug ’25US$3.85
US$4.15
+7.9%
14.1%US$4.98US$3.69n/a3
Jul ’25US$2.96
US$3.97
+34.1%
15.3%US$4.99US$3.39n/a4
Jun ’25US$3.40
US$4.19
+23.3%
15.8%US$5.00US$3.40n/a4
May ’25US$4.15
US$4.35
+4.8%
15.7%US$4.97US$3.40US$4.153
Apr ’25US$2.29
US$4.43
+93.3%
13.5%US$4.98US$3.59US$4.713
Mar ’25US$2.56
US$4.60
+79.3%
16.9%US$5.49US$3.60US$3.813
Feb ’25US$3.07
US$5.84
+90.2%
18.5%US$7.30US$4.71US$3.173
Jan ’25US$3.66
US$5.84
+59.7%
18.5%US$7.30US$4.71US$3.983
Dec ’24US$4.00
US$5.60
+40.0%
18.1%US$7.28US$4.70US$5.024
Nov ’24US$4.13
US$5.94
+44.0%
14.3%US$7.21US$4.84US$3.894
Oct ’24US$5.00
US$5.94
+18.8%
14.3%US$7.21US$4.84US$3.464
Sep ’24US$5.05
US$6.09
+20.6%
13.9%US$7.21US$4.84US$3.194
Aug ’24US$5.85
US$6.21
+6.1%
13.8%US$7.30US$4.90US$3.854
Jul ’24US$5.05
US$6.23
+23.4%
12.3%US$7.13US$5.00US$2.964
Jun ’24US$4.79
US$6.23
+30.1%
12.3%US$7.13US$5.00US$3.404
May ’24US$5.10
US$7.59
+48.8%
12.5%US$8.87US$6.61US$4.153
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
US$4.63
Fair Value
5.3% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 00:52
End of Day Share Price 2025/05/08 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Yatsen Holding Limited is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luzi LiBofA Global Research
Zhuonan XuChina International Capital Corporation Limited
Xiaofang XuCitic Securities Co., Ltd.